BFM
CELG

Boston Financial Management’s Celgene Corp CELG Stock Holding History

Boston Financial Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,317
Closed -$386K – 283
2018
Q3 		$386K Buy
+4,317
New +$382K 0.02% 228
2017
Q3 		– Sell
-1,801
Closed -$234K – 277
2017
Q2 		$234K Buy
+1,801
New +$221K 0.02% 253

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Financial Management's CELG Position: Q4 2018 in Review

Boston Financial Management sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 4,317 shares — an estimated $386K sold.

Boston Financial Management first reported a position in CELG in Q2 2017 and held it in 2 quarters. The position peaked at $386K in Q3 2018. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Boston Financial Management reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Boston Financial Management sold 4,317 Celgene Corp shares in Q4 2018, an estimated $386K.
  • Boston Financial Management first reported a position in Celgene Corp in Q2 2017 and held it in 2 quarters.
  • Boston Financial Management's Celgene Corp position peaked at $386K in Q3 2018.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Boston Financial Management's 13F filing for Q4 2018, filed 31 Jan 2019.